First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany

  • C. Wendt
  • S. Schütt
  • A. H. Dalpke
  • M. Konrad
  • M. Mieth
  • B. Trierweiler-Hauke
  • M. A. Weigand
  • S. Zimmermann
  • K. Biehler
  • D. Jonas
Article

Abstract

We report the first outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. The presence of KPC was confirmed by polymerase chain reaction (PCR). The KPC-encoding plasmid was analysed by transconjugation experiments, DNA sequencing, Southern blotting and isoelectric focussing. Typing was performed by pulsed-field gel electrophoresis (PFGE). An ertapenem-resistant K. pneumoniae with low minimum inhibitory concentrations (MIC) to other cabapenems (tested by the Vitek system) was isolated from the index patient in January 2008. A KPC-2 was identified after K. pneumoniae with identical susceptibility patterns had been isolated from two more patients. Despite the introduction of infection control measures, transmission occurred in five additional patients and three of the patients died from infections. The source of the outbreak strain remained unclear; however, the Tn4401-containing blaKPC-2 gene was similar to previously described isolates from Greece. Five months after the end of the outbreak, a KPC-K. pneumoniae was isolated from a patient who had been treated in Greece previously. Retrospectively, this patient was treated in November 2007 on the same unit as the index case. Typing revealed that all patients were colonised by the same strain. KPC-K. pneumoniae has been introduced to Germany possibly from Greece and transmission to other institutions is likely.

References

  1. 1.
    Queenan AM, Bush K (2007) Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 20:440–458CrossRefPubMedGoogle Scholar
  2. 2.
    Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC (2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–1161CrossRefPubMedGoogle Scholar
  3. 3.
    Bratu S, Mooty M, Nichani S, Landman D, Gullans C, Pettinato B, Karumudi U, Tolaney P, Quale J (2005) Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 49:3018–3020CrossRefPubMedGoogle Scholar
  4. 4.
    Lomaestro BM, Tobin EH, Shang W, Gootz T (2006) The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York. Clin Infect Dis 43:e26–e28, Epub 2006 Jun 19CrossRefPubMedGoogle Scholar
  5. 5.
    Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, Landman D, Rahal JJ, Brooks S, Cebular S, Quale J (2004) Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis 39:55–60CrossRefPubMedGoogle Scholar
  6. 6.
    Woodford N, Tierno PM Jr, Young K, Tysall L, Palepou MF, Ward E, Painter RE, Suber DF, Shungu D, Silver LL, Inglima K, Kornblum J, Livermore DM (2004) Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 48:4793–4799CrossRefPubMedGoogle Scholar
  7. 7.
    Naas T, Nordmann P, Vedel G, Poyart C (2005) Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 49:4423–4424CrossRefPubMedGoogle Scholar
  8. 8.
    Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, Quinn JP; Colombian Nosocomial Resistance Study Group (2006) First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 50:2880–2882CrossRefPubMedGoogle Scholar
  9. 9.
    Pasteran FG, Otaegui L, Guerriero L, Radice G, Maggiora R, Rapoport M, Faccone D, Di Martino A, Galas M (2008) Klebsiella pneumoniae carbapenemase-2, Buenos Aires, Argentina. Emerg Infect Dis 14:1178–1180CrossRefPubMedGoogle Scholar
  10. 10.
    Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ (2007) Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 51:763–765CrossRefPubMedGoogle Scholar
  11. 11.
    Samra Z, Ofir O, Lishtzinsky Y, Madar-Shapiro L, Bishara J (2007) Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 30:525–529CrossRefPubMedGoogle Scholar
  12. 12.
    Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y (2007) Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 51:3026–3029CrossRefPubMedGoogle Scholar
  13. 13.
    Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwaber MJ, Schwartz D, Carmeli Y (2006) Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 50:3098–3101CrossRefPubMedGoogle Scholar
  14. 14.
    Cuzon G, Naas T, Demachy MC, Nordmann P (2008) Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 52:796–797CrossRefPubMedGoogle Scholar
  15. 15.
    Tsakris A, Kristo I, Poulou A, Markou F, Ikonomidis A, Pournaras S (2008) First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J Antimicrob Chemother 62:1257–1260CrossRefPubMedGoogle Scholar
  16. 16.
    Tegmark Wisell K, Haeggman S, Gezelius L, Thompson O, Gustafsson I, Ripa T, Olsson-Liljequist B (2007) Identification of Klebsiella pneumoniae carbapenemase in Sweden. Euro Surveill 12:E071220.3PubMedGoogle Scholar
  17. 17.
    Woodford N, Zhang J, Warner M, Kaufmann ME, Matos J, Macdonald A, Brudney D, Sompolinsky D, Navon-Venezia S, Livermore DM (2008) Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 62:1261–1264CrossRefPubMedGoogle Scholar
  18. 18.
    Maltezou HC, Giakkoupi P, Maragos A, Bolikas M, Raftopoulos V, Papahatzaki H, Vrouhos G, Liakou V, Vatopoulos AC (2009) Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect 58:213–219CrossRefPubMedGoogle Scholar
  19. 19.
    Yigit H, Queenan AM, Rasheed JK, Biddle JW, Domenech-Sanchez A, Alberti S, Bush K, Tenover FC (2003) Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2. Antimicrob Agents Chemother 47:3881–3889CrossRefPubMedGoogle Scholar
  20. 20.
    Rasheed JK, Biddle JW, Anderson KF, Washer L, Chenoweth C, Perrin J, Newton DW, Patel JB (2008) Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J Clin Microbiol 46:2066–2069CrossRefPubMedGoogle Scholar
  21. 21.
    Zhang R, Zhou HW, Cai JC, Chen GX (2007) Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J Antimicrob Chemother 59:574–576CrossRefPubMedGoogle Scholar
  22. 22.
    Cai JC, Zhou HW, Zhang R, Chen GX (2008) Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 52:2014–2018CrossRefPubMedGoogle Scholar
  23. 23.
    Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y (2008) Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 52:1413–1418, Epub 2008 Jan 28CrossRefPubMedGoogle Scholar
  24. 24.
    Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM (2003) Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 47:1297–1300CrossRefPubMedGoogle Scholar
  25. 25.
    Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP; Colombian Nosocomial Resistance Study Group (2007) First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 51:1553–1555CrossRefPubMedGoogle Scholar
  26. 26.
    Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P (2008) Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene. Antimicrob Agents Chemother 52:1257–1263CrossRefPubMedGoogle Scholar
  27. 27.
    Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH (2001) Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 7:88–91CrossRefPubMedGoogle Scholar
  28. 28.
    Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402CrossRefPubMedGoogle Scholar
  29. 29.
    Pfaller MA, Hollis RJ, Sader HS (1992) PFGE of chromosomal DNA. In: Isenberg HD (ed) Clinical Microbiological Procedures Handbook. American Society for Microbiology, Washington DC, Section 10.5.cGoogle Scholar
  30. 30.
    Tenover F, Arbeit R, Goering R, Mickelsen P, Murray B, Persing D, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239PubMedGoogle Scholar
  31. 31.
    Jonas D, Spitzmüller B, Daschner FD, Verhoef J, Brisse S (2004) Discrimination of Klebsiella pneumoniae and Klebsiella oxytoca phylogenetic groups and other Klebsiella species by use of amplified fragment length polymorphism. Res Microbiol 155:17–23CrossRefPubMedGoogle Scholar
  32. 32.
    Jonas D, Biehler K, Hartung D, Spitzmüller B, Daschner FD (2005) Plasmid-mediated quinolone resistance in isolates obtained in German intensive care units. Antimicrob Agents Chemother 49:773–775CrossRefPubMedGoogle Scholar
  33. 33.
    National Committee for Clinical Laboratory Standards (NCCLS) (1997) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobially—Fourth Edition; Approved Standard M7-A4. NCCLS , Wayne, PAGoogle Scholar
  34. 34.
    Ejlertsen T, Skov R (1996) The β-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children. Acta Pathol Microbiol Immunol Scand 104:557–562Google Scholar
  35. 35.
    Watanabe M, Iyobe S, Inoue M, Mitsuhashi S (1991) Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 35:147–151PubMedGoogle Scholar
  36. 36.
    Wendt C, Jonas D (2008) Klebsiella-pneumoniae-carbapenemase in Deutschland nachgewiesen. Epidemiologisches Bulletin 22:173–174Google Scholar
  37. 37.
    Wang M, Sahm DF, Jacoby GA, Hooper DC (2004) Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother 48:1295–1299CrossRefPubMedGoogle Scholar
  38. 38.
    Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, Quale J (2005) Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 165:1430–1435CrossRefPubMedGoogle Scholar
  39. 39.
    Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, Landman D (2005) Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 56:128–132CrossRefPubMedGoogle Scholar
  40. 40.
    Tenover FC, Kalsi RK, Williams PP, Carey RB, Stocker S, Lonsway D, Rasheed JK, Biddle JW, McGowan JE Jr, Hanna B (2006) Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 12:1209–1213PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • C. Wendt
    • 1
  • S. Schütt
    • 1
  • A. H. Dalpke
    • 1
  • M. Konrad
    • 2
  • M. Mieth
    • 3
  • B. Trierweiler-Hauke
    • 3
  • M. A. Weigand
    • 2
  • S. Zimmermann
    • 1
  • K. Biehler
    • 4
  • D. Jonas
    • 4
  1. 1.Hygiene-InstituteUniversity of HeidelbergHeidelbergGermany
  2. 2.Clinic for AnaesthesiologyUniversity of HeidelbergHeidelbergGermany
  3. 3.Clinic for General, Visceral and Transplantation SurgeryUniversity of HeidelbergHeidelbergGermany
  4. 4.Department of Environmental Health ScienceFreiburg University Medical CentreFreiburgGermany

Personalised recommendations